BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 965 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $5,654,000 | -1.1% | 70,466 | -0.9% | 0.10% | -13.5% |
Q3 2020 | $5,718,000 | -8.6% | 71,102 | -2.1% | 0.11% | -11.9% |
Q2 2020 | $6,255,000 | +5.8% | 72,644 | -0.3% | 0.13% | -7.4% |
Q1 2020 | $5,914,000 | -2.9% | 72,845 | 0.0% | 0.14% | +16.2% |
Q4 2019 | $6,091,000 | -4.3% | 72,845 | +0.1% | 0.12% | -10.7% |
Q3 2019 | $6,362,000 | +14.8% | 72,738 | +7.5% | 0.13% | +12.9% |
Q2 2019 | $5,542,000 | +0.2% | 67,666 | -0.5% | 0.12% | +3.6% |
Q1 2019 | $5,529,000 | +20.4% | 68,002 | -2.5% | 0.11% | 0.0% |
Q4 2018 | $4,592,000 | -14.7% | 69,772 | -0.1% | 0.11% | +0.9% |
Q3 2018 | $5,385,000 | +5.5% | 69,849 | +1.1% | 0.11% | -0.9% |
Q2 2018 | $5,104,000 | +13.4% | 69,120 | -0.1% | 0.11% | +8.7% |
Q1 2018 | $4,502,000 | -0.2% | 69,221 | -0.9% | 0.10% | +2.0% |
Q4 2017 | $4,513,000 | +3.3% | 69,824 | +0.3% | 0.10% | -2.9% |
Q3 2017 | $4,367,000 | +6.6% | 69,587 | +2.8% | 0.10% | +1.0% |
Q2 2017 | $4,098,000 | +17.7% | 67,696 | +0.8% | 0.10% | +15.7% |
Q1 2017 | $3,483,000 | +17.3% | 67,171 | +0.3% | 0.09% | +11.2% |
Q4 2016 | $2,969,000 | -5.8% | 66,965 | +1.1% | 0.08% | -11.1% |
Q3 2016 | $3,152,000 | -6.3% | 66,219 | -11.0% | 0.09% | -8.2% |
Q2 2016 | $3,364,000 | +12.2% | 74,387 | +1.9% | 0.10% | +7.7% |
Q1 2016 | $2,998,000 | +10.0% | 72,978 | +2.1% | 0.09% | +7.1% |
Q4 2015 | $2,726,000 | +17.6% | 71,462 | +1.2% | 0.08% | +9.0% |
Q3 2015 | $2,319,000 | -52.7% | 70,585 | +0.7% | 0.08% | -48.0% |
Q2 2015 | $4,901,000 | +2.4% | 70,080 | +0.3% | 0.15% | +3.4% |
Q1 2015 | $4,787,000 | -80.7% | 69,876 | -79.3% | 0.14% | -16.7% |
Q4 2014 | $24,746,000 | +2.0% | 337,639 | -0.2% | 0.17% | -8.4% |
Q3 2014 | $24,271,000 | -0.9% | 338,175 | -0.1% | 0.19% | 0.0% |
Q2 2014 | $24,480,000 | -11.7% | 338,589 | -10.1% | 0.19% | -15.2% |
Q1 2014 | $27,718,000 | -20.4% | 376,703 | -24.8% | 0.22% | -21.1% |
Q4 2013 | $34,843,000 | +6.3% | 500,983 | +0.4% | 0.28% | -23.7% |
Q3 2013 | $32,767,000 | +4.6% | 498,816 | +10.3% | 0.37% | +8.1% |
Q2 2013 | $31,313,000 | – | 452,039 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |